Background Acute myocardial infarction (AMI) still has a high incidence of varying degrees
of heart failure (HF). The aim of this study is to identify new molecular markers for predicting …

Aims The pathogenesis of disease progression targets for patients with heart failure after
acute myocardial infarction was investigated by using plasma proteomics. Methods The …

Background: Acute myocardial infarction (AMI) is characterized by high mortality and
disability rates. Timely and effective revascularization has saved the lives of many patients …

Background Acute myocardial infarction (AMI) is an acute disease with high mortality and
seriously threatens human health. The identification of new effective biological markers for …

Heart failure (HF) is a syndrome with multiple clinical phenotypes affecting around 1%–2%
of adult population worldwide, and about 230 million Chinese are affected by cardiovascular …

Background Cardiac rupture (CR) is a rare but catastrophic mechanical complication of
acute myocardial infarction (AMI) that seriously threatens human health. However, the …

Acute myocardial infarction (AMI) remains a leading cause of morbidity and mortality
worldwide. Novel biomarkers are needed to identify NSTEMI in AMI patients. The study …

Acute myocardial infarction (AMI) is the one of the main cause of death worldwide.
Exosomes carry important information about intercellular communication and could be …

Background Both pathological and normal processes depend on proteins. In this study,
plasma protein profiles were analyzed by a novel proximity extension assay (PEA) to identify …

Background The associations of two novel inflammation biomarkers, systemic inflammation
response index (SIRI) and systemic immune inflammation index (SII), with mortality risk in …